Study Needs Infants, Children
The Clinical Center seeks infants 3-12 months and young children 1-5 years of age who are developing typically. The study aims to learn more about the motor skill and brain development of young children who are at high risk for or diagnosed with cerebral palsy (CP) and autism spectrum disorder (ASD) compared to young children with typical development. The results of this study may assist with better methods for early diagnosis as well as improved treatment for children with CP and ASD. This is an outpatient visit and all minor participants require parents’ permission to participate. To learn more, contact the Clinical Center Office of Patient Recruitment at 1-800-411-1222 or firstname.lastname@example.org. Refer to study 18-CC-0052. Read more at https://go.usa.gov/xpBJD.
Healthy Volunteers Needed
NIAID researchers seek healthy volunteers, 18-50 years old, for the study of an investigational product targeting malaria. Financial compensation is provided. To learn how to participate, call 1-866-833-5433 or email email@example.com.
Has Your Brain Tumor Returned?
Are you faced with glioblastoma (GBM) that has returned despite standard treatments? Partner with NINDS researchers in a study designed to look at the effects of two research drugs on the brain’s immune system in people who have had a return of GBM brain tumor. We will also look at the effects of these drugs on the brain tumor. All research-related care and experimental treatment is provided at no cost. The team at the Clinical Center Office of Patient Recruitment is standing by to help you: 1-800-411-1222 or firstname.lastname@example.org. Refer to study 18-N-0077. Read more at https://go.usa.gov/xEANh.
Patients with ALS Needed
Amyotrophic lateral sclerosis (ALS) research at NINDS is testing the effects of a combination of 4 drugs on the HERV-K levels in patients with elevated blood levels, and to see if this affects their ALS symptoms. Learn more by calling information specialists at the Clinical Center Office of Patient Recruitment, 1-866-444-2214 (800-877-8339 TTY/ASCII) or email@example.com. Refer to study 15-N-0126. Read more at https://go.usa.gov/xpWSn.